Paragraph 12 F1
Any activity which—
(a)
is carried on for the purpose of testing for the presence of severe acute respiratory syndrome coronavirus (“SARS-CoV-2”) in an individual, or for the presence of antibodies to SARS-CoV-2, or
(b)
is carried on for the purpose of processing, analysing or reporting the results of a test for the presence of SARS-CoV-2 in an individual, or for the presence of antibodies to SARS-CoV-2.